Business Insider5d
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, monobactam/beta-lactamase inhibitor combination antibiotic.
Business Insider5d
AbbVie: FDA Approves Emblaveo - Metronidazole Combination For Complicated Intra-Abdominal Infections
(RTTNews) - AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first fixed-dose, intravenous monobactam/ Beta -lactamase ...
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
Revealed: Boom in private market for medical cannabis
Medical cannabis is being marketed under brand names such as Ice Cream Cake while those most in need of the drug are being ...
New Scientist on MSN11h
Strongest evidence yet that Ozempic and Wegovy reduce alcohol intake
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
Vertex Forecasts Upbeat 2025 Revenue on Cystic Fibrosis Treatments Demand
Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...
NewsNation on MSN12h
Hims & Hers’ Super Bowl ad sparks weight loss drug backlash
It also touts the non-FDA-approved Hims & Hers weight-loss drug as the supreme and affordable solution to America’s obesity ...